Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

CheckedUp : Expands 3D and AI Capabilities Through Licensing Deal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2017 | 01:13am CEST

Integrated approach driven by smart data and personalized interactions

CheckedUp, a specialty point of care company, today announced that it has licensed 3D imaging technologies from Cirle, a medical technology incubator, for use in its patient engagement platform.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171110005763/en/

The SNS 200, Cirle’s second generation surgical navigation system, is one of the technologies Checke ...

The SNS 200, Cirle’s second generation surgical navigation system, is one of the technologies CheckedUp now has access to though a licensing agreement with Cirle. (Photo: Business Wire)

“We know the future of medicine lies in the ability to connect the patient and physician experience through an integrated approach that’s driven by smart data and personalized interactions,” said Richard Awdeh, M.D., CEO and Founder of CheckedUp. “Through this licensing agreement, we will be able to utilize the 3D capabilities that have proven effective in the surgical environment and bring them into the consultation room. In addition, we can begin to use artificial intelligence to determine smart inputs at consultation, which will lead to better outputs during surgery.”

The CheckedUp platform is designed to support the practice workflow by enabling better patient education and engagement. With the addition of this technology, CheckedUp can begin to uncover tendencies and correlations to develop predictive modeling that will drive intelligent strategic decisions and create personalized treatment plans for patients.

The Cirle SNS 200 is an ophthalmic image communications device that integrates procedural data, provides 3D guidance for cataract and refractive surgeries inside the ophthalmic microscope, and incorporates smart workflow automation that increases efficiency throughout the surgery. As a key component of this system, the eye tracking software allows for 3-dimensional, precise eye-tracking and intraoperative guidance during the surgical procedure.

Initially, CheckedUp will integrate 3D imaging into its interactive Consult wallboard solution to enhance the quality of information that practices provide patients during surgical consultations with 3D anatomical diagrams. The license also grants CheckedUp access to Cirle’s second generation surgical navigation system, SNS 200, as well as its eye registration software -- allowing CheckedUp to integrate the entire workflow from consultation to surgery through follow up with the seamless flow of data and patient information.

“Our focus is on using data to help patients and physicians make actionable decisions together,” said Dr. Awdeh. “The integration of this technology gives us a unique ability to lead in specialty point of care, enabling a patient and surgeon to integrate and optimize all information flow surrounding a surgical procedure.”

CheckedUp expects to begin providing 3D-capable technology upgrades to existing and new customers through the CheckedUp Consult wallboards during the first quarter of 2018 and initiate development efforts aimed at integrating the SNS 200 into the CheckedUp platform in 2018.

About CheckedUp

CheckedUp is the premier specialty technology platform at the point of care actively engaging patients and physicians in the waiting room, exam room and at home. As a health technology leader, CheckedUp aspires to create better educated and more confident patients and physicians who are empowered to make informed health decisions together. Learn more at www.CheckedUp.com.

About Cirle

Established in 2010, Cirle is a medical technology incubator based at the University of Miami Life Science and Technology Park in Miami, Fla. The company focuses on the use of translational medical research and innovative technologies to cure diseases that lead to blindness. It develops and acquires early-stage technologies, applies its specialized capabilities to refine and test them, and pursues industry collaborations to bring the technologies to market. Offering a highly interactive environment for interdisciplinary innovation, Cirle has engaged leading eye health experts, engineers and researchers in its development projects. For more information, visit www.cirle.com.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
11:03aINTERNATIONAL BUSINESS MACHINES : IBM is opening up the secrets of AI
AQ
11:03aCaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products
GL
11:02aBULTEN : Annual Report voted best in Sweden
AQ
11:02aCARETECH : Form 8.3 - CareTech Holdings
PU
11:02aRENESAS ELECTRONICS : IAR Systems enables high-quality automotive applications with major updates in Renesas RH850 tools
AQ
11:02aCYBG : Form 8.5 (EPT/RI) - CYBG plc
PU
11:02aST JOE : Community Foundation gives $262,500 to Bay District elementary schools to promote literacy
AQ
11:01aDermTech Announces Enrollment Completion of Clinical Study to Assess DNA Damage and Reversal
BU
11:01aGolden Predator Intercepts 8.5 meters of 5 g/t Gold at Brewery Creek Project; Drilling Extends Known Gold Mineralization over 200 m
GL
11:01aMINA THERAPEUTICS : Announces Findings From MTL-CEBPA Clinical Trial in Patients with Advanced Liver Cancer at International Liver Cancer Association Conference
BU
Latest news "Companies"
Advertisement